CYP19A1 and breast cancer: The anti-cancer effect of AIs mainly consists of the inhibition of aromatase enzyme, consequently inducing estrogen deprivation, which in turn is responsible for the inhibition of cell proliferation, through the cell cycle arrest in G0/G1 phase, and enhanced apoptosis in BC cells.